Colossal
250 employees
Biotech
Series C · $555.0M
Company details
Team Size250
IndustryBiotech
Funding
Total raised
$555.0M
Last stage
Series C
Investors
USIT
Total raised
$555.0M
Last stage
Series C
Investors
Ben Lamm
Serial technology entrepreneur with 5 prior exits (to Accenture, Zynga, LivePerson, and others). Co-founded Colossal Biosciences in 2021 with George Church to pursue de-extinction using CRISPR and genetic engineering.
LinkedIn
George Church
Harvard geneticist, Professor of Genetics at Harvard Medical School, and Professor of Health Sciences and Technology at Harvard and MIT. Pioneer in CRISPR gene editing and synthetic biology.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.